Latent Health Pharmacy Intelligence Platform

Latent Health provides an enterprise pharmacy intelligence platform powered by what it calls a clinical agentic engine. The site states more than 60 health systems use it, covering over five million patient medication journeys per year; the terms of use are governed by United States law, and no founding year is shown.

The platform works in four stages: identify every patient who needs a medication, secure access (including prior authorization and benefit work), deliver compliant treatment, and support patients afterwards. Named health-system customers include Mount Sinai, Cleveland Clinic, Mayo Clinic, Henry Ford Health, Ochsner Health, UNC Health and St. Luke's.

• Identify: finds every patient who qualifies for a medication across the health system.
• Access: automates benefit investigation and prior authorization to speed medication access.
• Treat: supports compliant care delivery for the pharmacy.
• Engage: patient support and follow-up across the medication journey.
• Autonomous agents: AI agents launched in September 2026 to streamline medication access work.
• Security: SOC 2 and HIPAA stated, with a public security report.

Large Vietnamese hospital groups with in-house pharmacies could study the patient-identification and access-automation model. Insurers and hospital pharmacy departments could adapt the agent approach to insurance claim pre-approval for costly drugs.

Cuts the manual work of medication access for pharmacy teams. Press items on the site describe prior authorization time reduced at Ochsner Health and MetroHealth. The platform covers the whole path from patient identification to ongoing engagement. SOC 2 and HIPAA are stated on the site.

Hospital and specialty pharmacies face growing prior authorization and access workloads as specialty drug volumes rise, which drives adoption of AI agents. Vietnamese hospital pharmacies are digitizing under national e-prescription linkage, but payer-driven authorization is a US-specific workflow.

Press page lists coverage in 2025 and 2026, including a Forbes article in March 2026 describing a 600 million USD valuation and partner announcements with Ochsner Health and Vanderbilt University Medical Center. Headquarters and founding year are not stated on the site.